ALKEM LABORATORIES
Back to All Ratios
|
ALKEM LABORATORIES Last 5 Year Cash Earnings per Share (CEPS) History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| CEPS(Rs) | 215.24 | 176.56 | 110.18 | 165.98 | 158.29 |
What is the latest Cash Earnings per Share (CEPS) ratio of ALKEM LABORATORIES ?
| Year | Cash Earnings per Share (CEPS) |
|---|---|
| Mar2025 | 215.24 |
| Mar2024 | 176.56 |
| Mar2023 | 110.18 |
| Mar2022 | 165.98 |
| Mar2021 | 158.29 |
How is Cash Earnings per Share (CEPS) of ALKEM LABORATORIES Trending?
| Years | Cash Earnings per Share (CEPS) | % Change | |
|---|---|---|---|
| Mar2025 | 215.24 | 21.91 | |
| Mar2024 | 176.56 | 60.25 | |
| Mar2023 | 110.18 | -33.62 | |
| Mar2022 | 165.98 | 4.86 | |
| Mar2021 | 158.29 | - | |
Other Financial Ratios of ALKEM LABORATORIES
| Operational & Financial Ratios Earnings Per Share DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Cash Earnings per Share (CEPS) ratio of peers of ALKEM LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALKEM LABORATORIES | ₹65,317.7 Cr | -2.8% | -1% | 22.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹419,728.0 Cr | -0.8% | 7.4% | 8.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹167,236.0 Cr | -1.5% | 5.7% | 11.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹146,951.0 Cr | -1.8% | 8.8% | 44.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,765.0 Cr | -1.2% | 9.2% | 14.9% | Stock Analytics | |
| CIPLA | ₹106,033.0 Cr | -2.5% | 0.1% | -7.6% | Stock Analytics | |
ALKEM LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALKEM LABORATORIES | -2.8% |
-1% |
22.1% |
| SENSEX | -3.8% |
-2% |
6.3% |
You may also like the below Video Courses